Table 6.
Anticancer effect of naringenin nanoparticles in in vivo studies.
| Nanomaterial Type | Cancer Type/Effect | Study Type | Reference |
|---|---|---|---|
|
PVA-eudragit
poly vinyl alcohol-Eudragit 500 |
ORAL SQUAMOUS CELL CARCINOMA anti-tumour effect | Animal model (hamster) | Krishnakumar N. et al., 2013 [79] |
| Eudragit | ORAL SQUAMOUS CELL CARCINOMA prevention of the tumour formation, reduction of the degree of histological lesions, anti-lipid peroxidative effect, anti-proliferative effect, antioxidant potential |
Animal model (hamster) | Sulfikkarali N. et al., 2013 [82] |
| Chitosan | LUNG CANCER antioxidant and anticancer activities (A549 cells) |
In vitro model | Kumar S. P. et al., 2015 [80] |
| Soluthin-maltodextrin | COLORECTAL CANCER enhanced oral bioavailability, tumour suppression in BALB/c mice-bearing colon-26 cells |
Animal model (rats) | Chaurasia S. et al., 2017 [81] |
|
NRG-EE100-NPs
(Eudragit 100) |
COLORECTAL CANCER enhanced oral bioavailability, tumour suppression in BALB/c mice-bearing colon-26 cells |
Animal model (rats) |
Chaurasia S. et al., 2018 [83] |
| Silk fibroin nanoparticles | CERVICAL CANCER anticancer potential HeLa cells |
In vitro model | Fuster M. G. et al., 2020 [78] |